Nyrada: Launches in vitro studies for brain injury program
Nyrada Launches in vitro studies for brain injury programNyrada (NYR) launches in vitro safety and toxicology studies as part of its brain injury...
Nyrada: Receives $1.3m R&D rebate for drug programs
Nyrada Receives $1.3m R&D rebate for drug programsNyrada (NYR) receives a $1.3 million research and development rebate
The rebate relates to expenditure on...
Nyrada: Partners with Walter Reed and UNSW for TBI program
Drug development company Nyrada (NYR) has partnered with the Walter Reed Army Institute of Research and UNSW Sydney for a preclinical program
The...

